$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Engineering Bacteroides thetaiotaomicron to produce non-native butyrate based on a genome-scale metabolic model-guided design

Metabolic engineering, v.68, 2021년, pp.174 - 186  

Kim, Kangsan ,  Choe, Donghui ,  Song, Yoseb ,  Kang, Minjeong ,  Lee, Seung-Goo ,  Lee, Dae-Hee ,  Cho, Byung-Kwan

초록이 없습니다.

참고문헌 (99)

  1. Front. Nutr. Adamberg 1 21 2014 10.3389/fnut.2014.00021 Degradation of fructans and production of propionic acid by Bacteroides thetaiotaomicron are enhanced by the shortage of amino acids 

  2. Front. Microbiol. Anand 7 1945 2016 10.3389/fmicb.2016.01945 Comparative in silico analysis of butyrate production pathways in gut commensals and pathogens 

  3. Biotechnol. Bioeng. Baek 110 2790 2013 10.1002/bit.24925 Butyrate production in engineered Escherichia coli with synthetic scaffolds 

  4. Microb. Cell Factories Bai 19 94 2020 10.1186/s12934-020-01350-z Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice 

  5. Int. J. Mol. Sci. Bai 21 2020 10.3390/ijms21103615 Production and sensing of butyrate in a probiotic Escherichia coli strain 

  6. Proc. Natl. Acad. Sci. U. S. A. Baughn 99 4662 2002 10.1073/pnas.052710199 A mitochondrial-like aconitase in the bacterium Bacteroides fragilis: implications for the evolution of the mitochondrial Krebs cycle 

  7. Microbiology (Read.) Baughn 149 1551 2003 10.1099/mic.0.26247-0 The essential role of fumarate reductase in haem-dependent growth stimulation of Bacteroides fragilis 

  8. PLoS Comput. Biol. Becker 4 2008 10.1371/journal.pcbi.1000082 Context-specific metabolic networks are consistent with experiments 

  9. Blaut 1997 Bioenergetics Energetics of Aerobic and Anaerobic Bacteria 

  10. Cell Host Microbe Brown 25 668 2019 10.1016/j.chom.2019.04.002 Bacteroides-derived sphingolipids are critical for maintaining intestinal homeostasis and symbiosis 

  11. Biotechnol. Bioeng. Burgard 84 647 2003 10.1002/bit.10803 Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization 

  12. Science Byndloss 357 570 2017 10.1126/science.aam9949 Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion 

  13. Science Cash 313 1126 2006 10.1126/science.1127119 Symbiotic bacteria direct expression of an intestinal bactericidal lectin 

  14. Arch. Microbiol. Caspari 135 16 1983 10.1007/BF00419476 The role of carbon dioxide in glucose metabolism of Bacteroides fragilis 

  15. mSystems Catlett 5 2020 10.1128/mSystems.00252-20 Metabolic feedback inhibition influences metabolite secretion by the human gut symbiont Bacteroides thetaiotaomicron 

  16. J. Bacteriol. Chang 181 6656 1999 10.1128/JB.181.21.6656-6663.1999 Acetate metabolism in a pta mutant of Escherichia coli W3110: importance of maintaining acetyl coenzyme A flux for growth and survival 

  17. Nat. Commun. Choe 10 935 2019 10.1038/s41467-019-08888-6 Adaptive laboratory evolution of a genome-reduced Escherichia coli 

  18. J. Ind. Microbiol. Biotechnol. Contiero 24 421 2000 10.1038/sj.jim.7000014 Effects of mutations in acetate metabolism on high-cell-density growth of Escherichia coli 

  19. J. Infect. Dis. Curtiss 137 668 1978 10.1093/infdis/137.5.668 Biological containment and cloning vector transmissibility 

  20. PLoS One Das 13 2018 10.1371/journal.pone.0195161 In vitro co-cultures of human gut bacterial species as predicted from co-occurrence network analysis 

  21. Anaerobe Degnan 1 25 1995 10.1016/S1075-9964(95)80392-0 Carbohydrate utilization patterns and substrate preferences in Bacteroides thetaiotaomicron 

  22. Inflamm. Bowel Dis. Delday 25 85 2019 10.1093/ibd/izy281 Bacteroides thetaiotaomicron ameliorates colon inflammation in preclinical models of Crohn's disease 

  23. Cell Metabol. Donohoe 13 517 2011 10.1016/j.cmet.2011.02.018 The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon 

  24. Science Faith 341 1237439 2013 10.1126/science.1237439 The long-term stability of the human gut microbiota 

  25. Curr. Opin. Microbiol. Feist 13 344 2010 10.1016/j.mib.2010.03.003 The biomass objective function 

  26. Cell Host Microbe Fischbach 10 336 2011 10.1016/j.chom.2011.10.002 Eating for two: how metabolism establishes interspecies interactions in the gut 

  27. Microbiology Folsom 161 1659 2015 10.1099/mic.0.000118 Physiological, biomass elemental composition and proteomic analyses of Escherichia coli ammonium-limited chemostat growth, and comparison with iron- and glucose-limited chemostat growth 

  28. mBio Garcia-Bayona 10 2019 10.1128/mBio.01762-19 Streamlined genetic manipulation of diverse Bacteroides and Parabacteroides isolates from the human gut microbiota 

  29. Gut Microb. Heinken 4 28 2013 10.4161/gmic.22370 Systems-level characterization of a host-microbe metabolic symbiosis in the mammalian gut 

  30. Nat. Biotechnol. Henry 28 977 2010 10.1038/nbt.1672 High-throughput generation, optimization and analysis of genome-scale metabolic models 

  31. Cell Host Microbe Hickey 17 672 2015 10.1016/j.chom.2015.04.002 Colitogenic Bacteroides thetaiotaomicron antigens access host immune cells in a sulfatase-dependent manner via outer membrane vesicles 

  32. Nature Human Microbiome Project 486 207 2012 10.1038/nature11234 Structure, function and diversity of the healthy human microbiome 

  33. Nat. Biotechnol. Isabella 36 857 2018 10.1038/nbt.4222 Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria 

  34. Science Jiang 363 181 2019 10.1126/science.aau5238 Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host adaptation in the gut 

  35. J. Exp. Med. Jimenez 216 1005 2019 10.1084/jem.20190609 Microbial therapeutics: new opportunities for drug delivery 

  36. Nucleic Acids Res. Kanehisa 47 D590 2019 10.1093/nar/gky962 New approach for understanding genome variations in KEGG 

  37. Briefings Bioinf. Karp 20 1085 2019 10.1093/bib/bbx085 The BioCyc collection of microbial genomes and metabolic pathways 

  38. J. Biosci. Bioeng. Kataoka 123 562 2017 10.1016/j.jbiosc.2016.12.008 Butyrate production under aerobic growth conditions by engineered Escherichia coli 

  39. Front. Immunol. Kespohl 8 1036 2017 10.3389/fimmu.2017.01036 The microbial metabolite butyrate induces expression of Th1-associated factors in CD4(+) T cells 

  40. Sci. Transl. Med. Kurtz 11 2019 10.1126/scitranslmed.aau7975 An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans 

  41. Mol. Microbiol. Lawhon 46 1451 2002 10.1046/j.1365-2958.2002.03268.x Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA 

  42. Nature Lee 501 426 2013 10.1038/nature12447 Bacterial colonization factors control specificity and stability of the gut microbiota 

  43. Appl. Microbiol. Biotechnol. Li 82 749 2009 10.1007/s00253-009-1857-3 A fluorescent, genetically engineered microorganism that degrades organophosphates and commits suicide when required 

  44. Cell Lim 169 547 2017 10.1016/j.cell.2017.03.045 Engineered regulatory systems modulate gene expression of human commensals in the gut 

  45. Nucleic Acids Res. Lombard 42 D490 2014 10.1093/nar/gkt1178 The carbohydrate-active enzymes database (CAZy) in 2013 

  46. Nat. Protoc. Long 14 2856 2019 10.1038/s41596-019-0204-0 High-resolution (13)C metabolic flux analysis 

  47. J. Bacteriol. Macy 123 436 1975 10.1128/jb.123.2.436-442.1975 Evidence for cytochrome involvement in fumarate reduction and adenosine 5'-triphosphate synthesis by Bacteroides fragilis grown in the presence of hemin 

  48. J. Bacteriol. Macy 134 84 1978 10.1128/jb.134.1.84-91.1978 Pathway of succinate and propionate formation in Bacteroides fragilis 

  49. Nature Mandell 518 55 2015 10.1038/nature14121 Biocontainment of genetically modified organisms by synthetic protein design 

  50. Cell Host Microbe Martens 4 447 2008 10.1016/j.chom.2008.09.007 Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont 

  51. J. Bacteriol. Mazumdar 191 74 2009 10.1128/JB.01123-08 Metabolic network model of a human oral pathogen 

  52. Cell Syst. Mimee 1 62 2015 10.1016/j.cels.2015.06.001 Programming a human commensal bacterium, Bacteroides thetaiotaomicron, to sense and respond to stimuli in the murine gut microbiota 

  53. Nat. Biotechnol. Monk 35 904 2017 10.1038/nbt.3956 iML1515, a knowledgebase that computes Escherichia coli traits 

  54. Nat. Methods Mortazavi 5 621 2008 10.1038/nmeth.1226 Mapping and quantifying mammalian transcriptomes by RNA-Seq 

  55. Exp. Mol. Med. Namai 52 1627 2020 10.1038/s12276-020-00507-5 Microbial therapeutics for acute colitis based on genetically modified Lactococcus lactis hypersecreting IL-1Ra in mice 

  56. Nature Ndeh 544 65 2017 10.1038/nature21725 Complex pectin metabolism by gut bacteria reveals novel catalytic functions 

  57. Cancer Gene Ther. Nemunaitis 10 737 2003 10.1038/sj.cgt.7700634 Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients 

  58. Nucleic Acids Res. Noronha 47 D614 2019 10.1093/nar/gky992 The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease 

  59. Nucleic Acids Res. Norsigian 48 D402 2020 BiGG Models 2020: multi-strain genome-scale models and expansion across the phylogenetic tree 

  60. Infection Olsen 27 159 1999 10.1007/BF02561521 A primer on anaerobic bacteria and anaerobic infections for the uninitiated 

  61. Nat. Biotechnol. Orth 28 245 2010 10.1038/nbt.1614 What is flux balance analysis? 

  62. Mol. Microbiol. Pan 39 1562 2001 10.1046/j.1365-2958.2001.02343.x How does oxygen inhibit central metabolism in the obligate anaerobe Bacteroides thetaiotaomicron 

  63. Front. Cell Infect. Microbiol. Pessione 2 86 2012 10.3389/fcimb.2012.00086 Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows 

  64. Cell Host Microbe Porter 22 494 2017 10.1016/j.chom.2017.08.020 A subset of polysaccharide capsules in the human symbiont Bacteroides thetaiotaomicron promote increased competitive fitness in the mouse gut 

  65. Trends Microbiol. Porter 26 966 2018 10.1016/j.tim.2018.08.005 Bacteroides thetaiotaomicron 

  66. Briefings Bioinf. Raman 10 435 2009 10.1093/bib/bbp011 Flux balance analysis of biological systems: applications and challenges 

  67. Cell Host Microbe Rivera-Chavez 19 443 2016 10.1016/j.chom.2016.03.004 Depletion of butyrate-producing Clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella 

  68. J. Bacteriol. Roberton 150 1056 1982 10.1128/jb.150.3.1056-1060.1982 Fructose 6-phosphate phosphorylation in Bacteroides species 

  69. Front. Microbiol. Rodriguez-Castano 10 1145 2019 10.3389/fmicb.2019.01145 Bacteroides thetaiotaomicron starch utilization promotes quercetin degradation and butyrate production by Eubacterium ramulus 

  70. Expert Rev. Vaccines Rothman 12 493 2013 10.1586/erv.13.34 Live-attenuated listeria-based immunotherapy 

  71. J. Agric. Food Chem. Saini 62 4342 2014 10.1021/jf500355p Metabolic engineering of Escherichia coli for production of butyric acid 

  72. Annu. Rev. Microbiol. Salyers 38 293 1984 10.1146/annurev.mi.38.100184.001453 Bacteroides of the human lower intestinal tract 

  73. Nat. Protoc. Schellenberger 6 1290 2011 10.1038/nprot.2011.308 Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 

  74. Inflamm. Bowel Dis. Schultz 14 1012 2008 10.1002/ibd.20377 Clinical use of E. coli Nissle 1917 in inflammatory bowel disease 

  75. BMC Bioinf. Sheydina 15 112 2014 10.1186/1471-2105-15-112 Structural genomics analysis of uncharacterized protein families overrepresented in human gut bacteria identifies a novel glycoside hydrolase 

  76. Sci. Rep. Shoaie 3 2532 2013 10.1038/srep02532 Understanding the interactions between bacteria in the human gut through metabolic modeling 

  77. Plasmid Smith 27 141 1992 10.1016/0147-619X(92)90014-2 Heterologous gene expression in Bacteroides fragilis 

  78. Proc. Natl. Acad. Sci. U. S. A. Song 117 7516 2020 10.1073/pnas.1912289117 Functional cooperation of the glycine synthase-reductase and Wood-Ljungdahl pathways for autotrophic growth of Clostridium drakei 

  79. Appl. Environ. Microbiol. Sperry 34 386 1977 10.1128/aem.34.4.386-390.1977 Requirement of heme for growth of Bacteroides fragilis 

  80. Nucleic Acids Res. Stead 40 e156 2012 10.1093/nar/gks680 RNAsnap: a rapid, quantitative and inexpensive, method for isolating total RNA from bacteria 

  81. Science Steidler 289 1352 2000 10.1126/science.289.5483.1352 Treatment of murine colitis by Lactococcus lactis secreting interleukin-10 

  82. J. Dairy Sci. Sun 103 8388 2020 10.3168/jds.2020-18189 Sodium butyrate reduces bovine mammary epithelial cell inflammatory responses induced by exogenous lipopolysaccharide, by inactivating NF-kappaB signaling 

  83. Bioinformatics Tepper 26 536 2010 10.1093/bioinformatics/btp704 Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways 

  84. Nat. Protoc. Thiele 5 93 2010 10.1038/nprot.2009.203 A protocol for generating a high-quality genome-scale metabolic reconstruction 

  85. Tingley 2019 Production and Secretion of Heterologous Immunomodulators in Bacteroides Thetaiotaomicron 

  86. mBio Ueki 5 2014 10.1128/mBio.01636-14 Converting carbon dioxide to butyrate with an engineered strain of Clostridium ljungdahlii 

  87. Nucleic Acids Res. Uniprot 47 D506 2019 10.1093/nar/gky1049 UniProt: a worldwide hub of protein knowledge 

  88. Appl. Microbiol. Varel 28 251 1974 10.1128/am.28.2.251-257.1974 Nutritional features of Bacteroides fragilis subsp. fragilis 

  89. Microbiome Vital 1 2013 A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community 

  90. Biotechnol. Biofuels Wang 12 62 2019 10.1186/s13068-019-1408-9 Metabolic engineering of Escherichia coli for the production of butyric acid at high titer and productivity 

  91. Cell Whitaker 169 538 2017 10.1016/j.cell.2017.03.041 Tunable expression tools enable single-cell Strain distinction in the gut microbiome 

  92. Microbiol. Mol. Biol. Rev. Wolfe 69 12 2005 10.1128/MMBR.69.1.12-50.2005 The acetate switch 

  93. Biosens. Bioelectron. Woo 168 2020 10.1016/j.bios.2020.112523 A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing 

  94. BMC Biol. Wrzosek 11 61 2013 10.1186/1741-7007-11-61 Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent 

  95. Science Xu 299 2074 2003 10.1126/science.1080029 A genomic view of the human-Bacteroides thetaiotaomicron symbiosis 

  96. PLoS One Yan 12 2017 10.1371/journal.pone.0179586 Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway 

  97. Front. Immunol. Yap 9 2617 2018 10.3389/fimmu.2018.02617 An insight into the intestinal web of mucosal immunity, microbiota, and diet in inflammation 

  98. Nat. Chem. Biol. Yim 7 445 2011 10.1038/nchembio.580 Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol 

  99. Nucleic Acids Res. Yoon 43 D624 2015 10.1093/nar/gku985 PAIDB v2.0: exploration and analysis of pathogenicity and resistance islands 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로